IMARC Group, a leading market research company, has recently releases report titled “Interventional Cardiology and Peripheral Vascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” The study provides a detailed analysis of the industry, including the global interventional cardiology and peripheral vascular devices market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big are the interventional cardiology and peripheral vascular devices market?
The global interventional cardiology and peripheral vascular devices market size reached US$ 23.08 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 38.28 Billion by 2028, exhibiting a growth rate (CAGR) of 8.10% during 2023-2028.
What are Interventional Cardiology and Peripheral Vascular Devices?
Interventional cardiology and peripheral vascular devices encompass a range of medical tools and equipment designed to diagnose and treat diseases of the heart and blood vessels. Interventional cardiology specifically focuses on minimally invasive techniques to address heart-related issues, employing devices, such as stents, catheters, and balloons. These enable the treatment of coronary artery disease, valvular heart disease, and other cardiovascular ailments with reduced recovery time and less trauma to the patient. Peripheral vascular devices target diseases of blood vessels outside the heart and brain, including those affecting the limbs, kidneys, and other organs. These devices assist in procedures to restore blood flow, reduce blockages, and treat aneurysms.
Request for a sample report or buy full report: https://www.imarcgroup.com/interventional-cardiology-peripheral-vascular-devices-market/requestsample
What are the growth prospects and trends in the interventional cardiology and peripheral vascular devices industry?
The rising incidence of heart diseases, peripheral artery disease, and other vascular conditions is escalating the demand for interventional treatments, which represents one of the key factors driving the growth of the market across the globe. In line with this, innovations in device design, materials, and imaging techniques are enhancing the effectiveness and safety of interventions, which is fueling the growth of the market. In addition to this, the aging global population is more susceptible to CVDs, which is leading to increased demand for interventional procedures and corresponding devices. The market is also driven by the shift towards minimally invasive surgeries, which often result in shorter recovery times and reduced hospital stays, thus boosting the preference for interventional cardiology and peripheral vascular devices. Investment in healthcare infrastructure, particularly in emerging economies, is expanding access to specialized cardiac care, which is creating a positive outlook for the market across the globe.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product Type:
- Inferior Vena Cava (IVC) Filters
- Plaque Modification Devices
- Hemodynamic Flow Alteration Devices
- Accessories
- Angioplasty Balloons
- Angioplasty Stents
- Angioplasty Catheters
- Endovascular Aneurysm Repair Stent Grafts
Breakup by Indication:
- Coronary Intervention
- Peripheral Arterial Disease
Breakup by Age Group:
- Geriatric
- Adults
- Paediatric
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Abbott Laboratories
- B. Braun Melsungen AG
- Becton Dickinson and Company
- Biotronik SE Co. KG
- Boston Scientific Corporation
- Cook Group Incorporated
- Cordis Corporation
- Koninklijke Philips N.V.
- Medtronic plc.
- Teleflex Incorporated
- Terumo Corporation
Ask Analyst for Customization and Browse full report with TOC List of Figure: https://www.imarcgroup.com/request?type=reportid=7542flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
